Status:
NOT_YET_RECRUITING
Effect of Early Lifestyle Intervention on Perinatal Outcomes in High-risk Women for Gestational Hyperglycemia
Lead Sponsor:
Tianjin Central Hospital of Gynecology Obstetrics
Conditions:
GDM
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
This study aims to explore whether early intervention for high-risk groups of gestational hyperglycemia can improve insulin resistance and effectively prevent the occurrence of GDM, and evaluate which...
Eligibility Criteria
Inclusion
- 18-55 years old
- 6-14 weeks of pregnancy
- at least one risk factor for GDM
- signed a written informed consent
Exclusion
- Individuals diagnosed with diabetes or prediabetes prior to pregnancy
- currently taking medications affecting blood glucose levels such as metformin
- women at risk of miscarriage
- individuals with chronic conditions (such as uncontrolled hypertension, severe heart disease)
- those with movement disorders or contraindicated conditions for physical activity
- patients undergoing gastrointestinal surgeries that alter glucose absorption
- those unable to maintain regular prenatal care (such as non-compliance with medical instructions or mental health issues).
Key Trial Info
Start Date :
August 20 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 20 2027
Estimated Enrollment :
604 Patients enrolled
Trial Details
Trial ID
NCT07141173
Start Date
August 20 2025
End Date
August 20 2027
Last Update
August 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tianjin Central Hospital of Gynecology Obstetrics
Tianjin, China, 300100